Evidence map›Paper›PMID 39575157›Full record

ReviewTherapeutic advances in gastroenterology2024

Inflammatory bowel disease: a narrative review of disease evolution in South Asia and India over the last decade.

Sahana Shankar, Snehali Majumder, Suparna Mukherjee, Anirban Bhaduri, Rangarajan Kasturi, Subrata Ghosh, Marietta Iacucci, Uday N Shivaji

Abstract readReview
In one paragraph

Review in Therapeutic advances in gastroenterology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Global burden of inflammatory bowel disease in Asia, 1990-2023: A global burden of disease study 2023.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026
    Article
  3. Article
  4. Article
  5. Inflammatory Bowel Disease in Jordanian Children: A Tertiary Center Experience.Pediatric gastroenterology, hepatology & nutrition · 2025
    Article
  6. Bone Health in Paediatric Inflammatory Bowel Disease.Diagnostics (Basel, Switzerland) · 2025
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sahana ShankarDivision of Paediatric Gastroenterology, Department of Paediatrics, Mazumdar Shaw Medical Center, NH Health City, Bangalore, India.ORCID https://orcid.org/0000-0002-8162-2324
Snehali MajumderDepartment of Clinical Research, Narayana Hrudayalaya, NH Health City, Bangalore, India APC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Suparna MukherjeeDepartment of Clinical Nutrition and Dietetics, Narayana Hrudayalaya, NH Health City, Bangalore, India.
Anirban BhaduriDhiyo Healthcare Analytics, Bangalore, India.
Rangarajan KasturiDepartment of Gastroenterology, Mazumdar Shaw Medical Center, a Unit of Narayana Health, Bangalore, India.
Subrata GhoshAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Marietta IacucciAPC Microbiome Ireland, College of Medicine and Health, University College Cork, Cork, Ireland.
Uday N ShivajiInstitute of Immunology and Immunotherapy, University of Birmingham, 2nd Floor, Institute of Translational Medicine, Heritage Building, Mindelsohn Way, Birmingham B15 2TH, UK Department of Gastroenterology, Mazumdar Shaw Medical Center, a Unit of Narayana Health, Bangalore, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid emergence of inflammatory bowel disease (IBD) in Asia in the last two decades is anticipated to pose significant challenges to the healthcare systems of developing countries including India. Several epidemiological factors in the Asia Pacific region have been explored as risk factors for the development of IBD. In this narrative review, we discuss the evolution of adult-onset and paediatric IBD in South Asia and India, in relation to the current global epidemiology, over the last decade. The focus lies on the changing epidemiological landscape of IBD in Asia which signals a paradigm shift in the disease trajectory of a chronic, relapsing, complex disease. We enumerate the disease burden of IBD in India and Asia, analyse the risk factors for its recent rise in incidence and briefly discuss the unique entity of very early-onset IBD. We also list the locoregional challenges in diagnosis and management along with suggestions to overcome them. We highlight the lacunae in data which warrants further research. The anticipated infrastructural challenges and disease evolution are likely to be similar in most newly industrialized countries across South Asia. A combined effort led by IBD experts in the region to understand the true disease burden is important. A strong collaborative network on research and formulation of preventive strategies relevant to the region will help reduce the burden in the future.

Indexed as

AsiaepidemiologyIBDIBD in Indiapaediatric IBDvery early-onset IBD

Identifiers

PMID39575157
PMCPMC11580062

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.